Geniposide ameliorates brain injury in mice with intracerebral hemorrhage by inhibiting NF-κB signaling

Neurol Res. 2024 Apr;46(4):346-355. doi: 10.1080/01616412.2024.2321014. Epub 2024 Feb 25.

Abstract

Background: Neuroinflammation and oxidative stress are critical players in intracerebral hemorrhage (ICH). Geniposide is an active component of Gardenia that has anti-inflammatory effects. This study focused on the roles and mechanisms of geniposide in ICH.

Methods: ICH was established by injecting collagenase IV into C57BL/6 mice. To determine the functions of geniposide and NF-κB inhibition in ICH model mice, geniposide (1, 25, or 50 mg/kg) or PDTC (a NF-κB inhibitor) was administered. Neurological functions were assessed with the modified neurological severity score (mNSS) test. Hematoxylin and eosin staining were performed to identify pathological changes. IL-1β and TNF-α levels were estimated with ELISA kits. NF-κB p65 localization was determined by immunofluorescence staining. Oxidative stress was analyzed by measuring ROS levels.

Results: Geniposide alleviated cerebral edema and neurological deficits. Geniposide inhibited neuroinflammation and oxidative stress after ICH, and the inhibitory effects were enhanced by NF-κB inhibition. Additionally, geniposide inhibited NF-κB signaling.

Conclusion: Geniposide alleviates brain injury by suppressing inflammation and oxidative stress damage in experimental ICH models by inhibiting NF-κB signaling.

Keywords: Intracerebral hemorrhage; NF-κB; geniposide; inflammation; oxidative damage.

MeSH terms

  • Animals
  • Brain Injuries*
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / drug therapy
  • Cerebral Hemorrhage / pathology
  • Iridoids*
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B*
  • Neuroinflammatory Diseases
  • Signal Transduction

Substances

  • geniposide
  • Iridoids
  • NF-kappa B